| First Author | Lu X | Year | 2011 |
| Journal | Mol Cancer Res | Volume | 9 |
| Issue | 4 | Pages | 430-9 |
| PubMed ID | 21385880 | Mgi Jnum | J:205228 |
| Mgi Id | MGI:5544391 | Doi | 10.1158/1541-7786.MCR-10-0277 |
| Citation | Lu X, et al. (2011) Apoptosis is the essential target of selective pressure against p53, whereas loss of additional p53 functions facilitates carcinoma progression. Mol Cancer Res 9(4):430-9 |
| abstractText | The high frequency of p53 mutation in human cancers indicates the important role of p53 in suppressing tumorigenesis. It is well established that the p53 regulates multiple, distinct cellular functions such as cell-cycle arrest and apoptosis. Despite intensive studies, little is known about which function is essential, or if multiple pathways are required, for p53-dependent tumor suppression in vivo. Using a mouse brain carcinoma model that shows high selective pressure for p53 inactivation, we found that even partially abolishing p53-dependent apoptosis by Bax inactivation was sufficient to significantly reduce the selective pressure for p53 loss. This finding is consistent with previous reports that apoptosis is the primary p53 function selected against during Emu-myc-induced mouse lymphoma progression. However, unlike observed in the Emu-myc-induced lymphoma model, attenuation of apoptosis is not sufficient to phenocopy the aggressive tumor progression associated with complete loss of p53 activity. We conclude that apoptosis is the primary tumor suppressive p53 function and the ablation of additional p53 pleiotropic effects further exacerbates tumor progression. |
